-
1
Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups
Published 2025-02-01Subjects: Get full text
Article -
2
The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana
Published 2025-01-01Subjects: Get full text
Article